Association Between High Faecal Calprotectin, Increased Intestinal Permeability and Visceral Hypersensitivity in IBS-D Patients
NCT02550704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2022-05-26
Summary
Visceral hypersensitivity, low grade inflammation and increased intestinal permeability are three main pathophysiological mechanisms involved in irritable bowel syndrome. The connexion between these abnormalities is not known. We hypothesis there is a link between them in IBS with diarrhoea.
Conditions
- Irritable Bowel Syndrome
Interventions
- PROCEDURE
-
Colonoscopy with eleven biopsies in the left colon to assess intestinal permeability
Eleven colonic biopsies are taken in the left colon during colonoscopy. Intestinal permeability is assessed by western blot, qPCR and immunofluorescence for claudin, occludin and ZO-1.
Sponsors & Collaborators
-
Société Nationale Française de Gastroentérologie
collaborator OTHER -
University Hospital, Rouen
lead OTHER
Principal Investigators
-
Chloé Melchior, MD · University Hospital, Rouen
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-20
- Primary Completion
- 2021-05-20
- Completion
- 2021-05-20
Countries
- France
Study Locations
More Related Trials
-
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D
NCT06543498 ·Status: COMPLETED ·Phase: NA
-
Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in Korea
NCT02003807 ·Status: COMPLETED
-
Fecal Amino Acids,Gut Taste Receptors and Irritable Bowel Syndromes
NCT06489444 ·Status: RECRUITING
-
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
NCT02981888 ·Status: COMPLETED
-
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
NCT06801184 ·Status: RECRUITING
-
Neurotrophic Factors, Tight Junction Proteins, and Cytokines in IBS
NCT03675100 ·Status: COMPLETED ·Phase: NA
-
Altered Faecal Protease Activity in Irritable Bowel Syndrome Patients in China
NCT01060527 ·Status: UNKNOWN
-
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 ·Status: COMPLETED ·Phase: NA
-
New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.
NCT07337707 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel
NCT00742118 ·Status: UNKNOWN ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Microbiota Profiling in IBS
NCT03720314 ·Status: COMPLETED
-
Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring Colonoscopy
NCT03806959 ·Status: COMPLETED ·Phase: NA
-
Effects of Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D Patients
NCT05593367 ·Status: UNKNOWN
-
Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS)
NCT01787253 ·Status: COMPLETED
-
Gut Microbiome in Inflammatory Bowel Disease
NCT03589183 ·Status: RECRUITING
-
ConfocAl endomicroSCopy bAsed Diet Trial in IBS
NCT05097872 ·Status: RECRUITING ·Phase: NA
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Pathophysiological Effects of Persistently Colonized Microbiome on Irritable Bowel Syndrome
NCT06013410 ·Status: RECRUITING ·Phase: NA
-
Gut Microbiota Dysbiosis and Translocation During IBD and Parkinson
NCT04159727 ·Status: COMPLETED ·Phase: NA
-
Small and Large Bowel Transit Tests Using MRI (Study 1)
NCT01534507 ·Status: COMPLETED
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Confocal Laser Endomicroscopy in IBS Patients
NCT02313207 ·Status: WITHDRAWN ·Phase: NA
-
Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D
NCT06676514 ·Status: COMPLETED ·Phase: NA
-
Changes in Microbiota and Metabolomic Profile Between Rifaximin Responders and Non-responders In Diarrhoea-Predominant Irritable Bowel Syndrome
NCT03557788 ·Status: COMPLETED ·Phase: PHASE4